Abstract
Background and Aim: Coagulation parameters in CLD are generally towards an anticoagulant state. However, risk of venous thrombosis and risk of procedure related bleeding is not predicted by abnormal coagulation testing. An altered coagulation test results to unwarranted transfusion of blood and blood products which can lead to administration of unneeded or even harmful pro-haemostatic factors. Thromboelastography(TEG) assesses the combined haemostatic potential and guide in transfusion in patients with CLD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
